Home Markets AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 Andrew M Sep 11, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/abbvie-shares-hit-record-high-as-key-immunology-drug-set-for-exclusivity-until-2037-4235812 ABBVIE Market Updates Pharmaceuticals (NEC) www.investing.com/news/stock-market-news/abbvie-shares-hit-record-high-as-key-immunology-drug-set-for-exclusivity-until-2037-4235812